Skip to Main Content

Lymphoblastic Lymphoma Treatment

Also called LLy, LBL, acute lymphoblastic lymphoma, T-lymphoblastic lymphoma (T-LL), B-lymphoblastic lymphoma (B-LL), precursor lymphoblastic lymphoma

Lymphoblastic lymphoma (LLy or LBL) is a type of cancer called non-Hodgkin lymphoma, which affects white blood cells called lymphocytes. These cells are important for fighting infections and are made from cells in the bone marrow called lymphoblasts

Changes in these cells may affect their function, and they can become cancerous. These cancerous cells can spread to other parts of the body, such as the lymph nodes and the thymus gland, which lies in the upper part of the chest.

There are 2 types of lymphoblastic lymphoma:

  • T-lymphoblastic lymphoma (T-LL) develops in the mediastinum, the space between the lungs. If it spreads to the blood and bone marrow, it becomes T-acute lymphoblastic leukemia (T-ALL).
  • B-lymphoblastic lymphoma (B-LL) starts in B cells and grows more slowly, often in the skin, bones, or lymph nodes. If it spreads to the blood and 25% or more of the bone marrow, it becomes B-acute lymphoblastic leukemia (B-ALL).

Learn more about lymphoblastic lymphoma on the Together by St. Jude™ online resource.

Treatment of lymphoblastic lymphoma

The treatment plan for lymphoblastic lymphoma depends on: 

  • The type of lymphoma and any gene (DNA) changes
  • How well it responds to treatment
  • Available treatments 
  • Age and health of patient
  • The patient’s risk of relapse

Treatment may include:

Your child’s oncologist will discuss treatment options with you.  

Lymphoblastic lymphoma clinical trials

St. Jude offers clinical trials and cancer research studies for children, teens, and young adults for lymphoblastic lymphoma.

Learn more about clinical research at St. Jude.

Recruiting
INITIALL: Risk-based Pediatric Leukemia/Lymphoma Treatment

Study goal:

To find out whether a child’s leukemia or lymphoma is low-risk, standard-risk, or high-risk. The risk category will determine the treatment the child will receive. 

Age:

1-18 years

Recruiting
SJALL23H: Treatment of High-Risk Leukemia/Lymphoma

Study goal:

To compare the effects of adding inotuzumab and blinatumomab to standard chemotherapy during treatment for newly diagnosed ALL and LLy; to learn whether the length of time that inotuzumab stays in the body affects treatment success or side effects; to learn more about the biological and genetic or genomic traits that predict treatment success and toxicity in children. 

Age:

1-18 years

Recruiting
SJALL23T: Treatment of Newly Diagnosed Leukemia/Lymphoma

Study goal:

To compare the effects of adding venetoclax, dasatinib, or bortezomib to standard chemotherapy for T-ALL, T-LLy, and MPAL, and to learn more about the biological and genetic or genomic traits that predict treatment success and toxicity in children.

Age:

1-18 years

Lymphoblastic lymphoma care at St. Jude

St. Jude provides the highest quality of care for patients with lymphoblastic lymphoma.

  • At St. Jude, we have created an environment where children can be children and families can be together.  
  • We are consistently ranked among the best childhood cancer centers in the nation by US News & World Report.
  • St. Jude offers a dedicated team of specialists to meet the needs of children with cancer, including:
  • We lead more clinical trials for childhood cancer than any other hospital in the U.S.
  • St. Jude is the only National Cancer Institute–designated Comprehensive Cancer Center just for children. A Comprehensive Cancer Center meets rigorous standards for research to develop new and better approaches to prevent, diagnose, and treat cancer. 
  • The nurse-to-patient ratio at St. Jude is about 1:3 in hematology and oncology and 1:1 in the Intensive Care Unit. 
  • Patients may be able to get expert, compassionate care and treatment closer to their homes through the St. Jude Affiliate Program. 
A statue of children running and holding hands

Seeking treatment at St. Jude

Patients accepted to St. Jude must have a disease we treat and must be referred by a physician or other qualified medical professional. We accept most patients based on their ability to enroll in an open clinical trial.

How to seek treatment

Contact the Physician / Patient Referral Office

Call: 1-888-226-4343 (toll-free) or 901-595-4055 (local)  | Fax: 901-595-4011 | Email: referralinfo@stjude.org | 24-hour pager: 1-800-349-4334

 

Learn More